Medcenter

Vijay Pande’s exit from a16z Bio + Health signals an inflection point for tech‑enabled medicine Andreessen Horowitz shocked Silicon Valley on 10 June 2025 when TechCrunch broke the news that Vijay Pande, the founding partner of its Bio + Health franchise, is stepping down after more than a decade at the helm. Pande leaves behind four dedicated bio funds that have deployed nearly $3 billion, landmark investments in…

The transformation unfolding across healthcare today is nothing short of revolutionary. At its core lies the dramatic acceleration of computing power: processors that once handled mere millions of operations per second now operate in the trillions, and cloud infrastructures enable anyone—whether a researcher in a major academic center or a clinician in a rural clinic—to…

The quiet revolution in machine‑intelligent medicine has reached critical mass. In March the U.S. Food and Drug Administration confirmed that more than one thousand medical devices incorporating artificial‑intelligence or machine‑learning algorithms are now cleared for marketing in the United States—a roughly tenfold jump in only eight years. The FDA’s public list, introduced in 2020 and…

The future of healthcare isn’t just changing—it’s being completely reimagined. And it’s happening faster than most people realize. Imagine walking into a doctor’s office where your AI physician knows your complete medical history, can diagnose rare conditions in seconds, and is available 24/7 at virtually no cost. This isn’t science fiction—according to tech visionary Vinod…